| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/06/2006 | WO2005058814A3 Biocidal siloxane coating material containing n-halogenated amine and amide functional groups |
| 04/06/2006 | US20060074121 Bicyclic and bridged nitrogen heterocycles |
| 04/06/2006 | US20060074099 5-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-ylmethyl]-thiophene-3-carboxylic acid; cell-cell and cell-substrate adhesion inhibitor; industrial scale; cyclization with condensed methylene precursor compound and glycine; separation of enantiomeric mixture |
| 04/06/2006 | US20060074087 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/06/2006 | US20060074074 Reacting compounds such as 5-(3,4-dimethoxybenzoyl)-2-(1-isopropoxycarbonyloxy-2-methylpropyl)-2-1,2,3-triazole-4-carboxylate with carbonyl compounds, reacting with an alcohol to produce 1-(1-Isopropoxycarbonyloxyethyl)-7,8-dimethoxy-4(5H),10-dioxo-1H-1,2,3-triazolo[4,5-c][1]benzazepine |
| 04/06/2006 | US20060074070 1-Methyl, 2-((2-(2-(guanidinoethyl(dimethylammonium)ethyl-)(naphthyl-1,5-ylene)oxymethyl-),6-(1-hydroxyethyl-)carbapen-2-em-3-carboxylate; 1-methylcarbapenems as bactericides; drug resistance; multidrug resistance; methicillin-resistant Staphylococcus aureus (MRSA) and S. epidermidis(MRSE) |
| 04/06/2006 | US20060074068 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 04/06/2006 | US20060074062 Substituted porphyrins |
| 04/06/2006 | US20060074056 Inhibitors of VEGF receptor and HGF receptor signaling |
| 04/06/2006 | US20060073472 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 04/06/2006 | DE4439243B4 Kationische Aluminium-Phthalocyaninfarbstoffe Cationic aluminum phthalocyanine |
| 04/06/2006 | DE102004047257A1 Phosphor-haltige Heptazinderivate, Verfahren zu deren Herstellung und deren Verwendung Phosphorus-containing heptazine derivatives, processes for their preparation and their use |
| 04/06/2006 | DE102004042441A1 Mit Aminosäuren substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel With amino acids substituted hexahydro-pyrazino (1,2-a) pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments |
| 04/06/2006 | CA2582777A1 Proton pump inhibitors |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 04/05/2006 | EP1642900A1 Tricyclic triazolobenzazepine derivative produced as novel crystalline substance |
| 04/05/2006 | EP1641802A2 Process for the preparation of furopyrroles |
| 04/05/2006 | EP1641801A2 Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors |
| 04/05/2006 | EP1641800A1 Pyrazolopyrimidines |
| 04/05/2006 | EP1641799A1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
| 04/05/2006 | EP1641798A1 Triazolopyrimidines |
| 04/05/2006 | EP1641797A1 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo `2, 3d]pyrimidine hydrogen mesylate and its polymorphic forms |
| 04/05/2006 | EP1641795A1 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals |
| 04/05/2006 | EP1641423A2 Benzodiazepine cgrp receptor antagonists |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | CN1756757A Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents |
| 04/05/2006 | CN1756553A 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249070C Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same |
| 04/05/2006 | CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/05/2006 | CN1249065C Improved process for carbapenem synthesis |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/04/2006 | US7022860 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10 -dioxo-2H-1,2,3-triazolo(4,5-c)(1)benzazepine, for example; chemical intermediates, synthesis using relatively inexpensive reagents |
| 04/04/2006 | US7022852 such as 1-C-(5-N-benzyloxymethyl-4-methoxy pyrrolo[3,2-d]pyrimidin-7-yl)-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol; potent inhibitors of purine nucleoside phosphorylase and useful for suppressing T-cell function and/or treating and/or preventing infections caused by protozoan parasites |
| 04/04/2006 | US7022850 Bicyclicpyrimidones and their use to treat diseases |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022847 Reacting benzamide derivative with haloketone compound to form imidazotriazine compound |
| 04/04/2006 | US7022843 improved photosensitizers useful in photodynamic therapy (PDT); diphenyl-2,3-dihydroxychlorin and its analogs which have increased toxicities for the destruction of unwanted cells, tissues or other undesirable materials by irradiation |
| 04/04/2006 | US7022841 Process for making carbapenem compounds |
| 04/04/2006 | US7022840 Porphyrin array exhibiting large two photon absorption property and including, as structural unit, bis (imidazolylporphyrin metal complex) linked with acetylenic bond and the derivative thereof, and method of producing the same |
| 04/04/2006 | US7022734 Use of a transition metal complex, other than deferoxamine-manganese, hemin, diethyldithiocarbamic acid complexes or an iron hemoprotein, in the manufacture of a medicament for the therapy of septic shock |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 04/04/2006 | US7022724 Cognition enhancing derivatives of isoxazole triazoloindane GABA-A α5 receptor subunit ligands |
| 04/04/2006 | US7022720 Synthetic diazonamides as novel anti-mitotic agents |
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022704 5,6,7, 8-tetrahydro-imidazo-(1,2a)-pyrazine derivative; useful for treating restenosis and tumor |
| 04/04/2006 | US7022699 Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| 04/04/2006 | US7022694 Indoles and indolines having 5-HT activity |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 04/04/2006 | US7022420 Assembled hematin, method for forming same and method for polymerizing aromatic monomers using same |
| 04/04/2006 | US7022312 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 04/04/2006 | CA2356544C Pyridotriazines and pyridopyridazines |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 03/30/2006 | WO2006034312A1 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
| 03/30/2006 | WO2006034116A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | WO2006034015A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors |
| 03/30/2006 | WO2006033848A1 Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 03/30/2006 | WO2006033007A2 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| 03/30/2006 | WO2006032994A2 Muscarinic receptor antagonists |
| 03/30/2006 | WO2006032631A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/30/2006 | WO2006032519A1 Tricycles, their manufacture and use as pharmaceutical agents |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 03/30/2006 | WO2005105820A3 Macrocyclic cadmium complexes |
| 03/30/2006 | WO2005097107A3 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 03/30/2006 | WO2005094251A3 M3muscarinic acetylcholine receptor antagonists |
| 03/30/2006 | WO2005040169A3 Fused heterocyclic compounds as serotonin receptor modulators |
| 03/30/2006 | WO2005037825A3 Protein kinase inhibitors |
| 03/30/2006 | WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/30/2006 | US20060069145 Tricycles, their manufacture and use as pharmaceutical agents |
| 03/30/2006 | US20060069111 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome |
| 03/30/2006 | US20060069106 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 03/30/2006 | US20060069102 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease |
| 03/30/2006 | US20060069099 Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 03/30/2006 | US20060069097 N-[3-(trifluoromethyl)phenyl]-4-{2-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-b]pyridazin-3-yl}pyrimidin-2-amine; enzyme inhibitors; inhibition/antagonism of protein kinases, glycogen synthase kinase-3-beta; central nervous system disorders; Alzheimer's disease; bipolar disorder; stroke; anticarcinogenic |
| 03/30/2006 | US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/30/2006 | US20060069085 Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069081 beta -methyl carbapenem compounds; for multiple-drug resistant bacterial strain |
| 03/30/2006 | US20060069077 Receptor-type kinase modulators and methods of use |
| 03/30/2006 | US20060068336 crystal structure; photosensitivity; cyan couplers |
| 03/30/2006 | DE102004046530A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
| 03/30/2006 | CA2581657A1 Thrombopoietin receptor agonists |
| 03/30/2006 | CA2581150A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors |
| 03/30/2006 | CA2580781A1 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
| 03/30/2006 | CA2580725A1 Novel heterocyclic nf-kb inhibitors |
| 03/30/2006 | CA2580610A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | CA2580203A1 Tricycles, their manufacture and use as pharmaceutical agents |
| 03/29/2006 | EP1640368A2 Cyclic ureas and processes for their preparation |
| 03/29/2006 | EP1638974A2 Triazolopyrimidines |
| 03/29/2006 | EP1638967A2 Cycloalkanepyrrolopyridines as dp receptor antagonists |
| 03/29/2006 | EP1638966A2 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO ¬3,4-d| PYRIMIDINE AND PYRROLO ¬2,3-d| PYRIMIDINE AND USES THEREOF |
| 03/29/2006 | EP1638957A1 N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 03/29/2006 | EP1638954A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors |
| 03/29/2006 | EP1638947A2 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1 |
| 03/29/2006 | EP1638944A1 Tachykinin receptor antagonists |
| 03/29/2006 | EP1638935A1 Nk1 antagonist |
| 03/29/2006 | EP1638677A2 Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides |
| 03/29/2006 | EP1638612A2 Cox-2-targeted imaging agents |